A New Fast-acting Sublingual Fentanyl (Recivit®) for Treating Breakthrough Cancer Pain
European Oncology & Haematology, 2014;10(1):12–6
Dr Mitchell describes the evolution of the interventional cancer pain service at the Beatson Oncology Centre in Glasgow. The development of the ITDD (Intrathecal Drug Delivery Service) is discussed...
Oncology experts discuss the problem of chemotherapy-induced nausea and vomiting (CINV) in cancer treatment and compare how they would manage a difficult case of delayed CINV.
Dr Nichola Gale discusses research into the role of exercise in patients with cancer cachexia, which was funded by a Tenovus Innovation grant.
Dr. Martin Blackstein, Staff Medical Oncologist and Dr. Jay Wunder, Surgeon-in-Chief talk about sarcoma and the how Mount Sinai has lead the way to improving cure rates.